Financials

News Ideas Discussions Technicals Forecast Seasonals

VIRX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Viracta Therapeutics, Inc.

Total assets of VIRX for Q2 24 is 31.32 M USD, 24.22% less than the previous Q1 24. And total liabilities decreased by 5.30% in Q2 24 to 28.65 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—